Severely Impaired Baroreflex-Buffering in Patients With Monogenic Hypertension and Neurovascular Contact

Background—We identified a family with a monogenic syndrome of hypertension, brachydactyly, and neurovascular contact of the brain stem. Neurovascular contact of the ventrolateral medulla may lead to arterial hypertension by interfering with baroreflex function. Methods and Results—In 5 patients with monogenic hypertension (18 to 34 years old), we conducted detailed autonomic function tests. Blood pressure during complete ganglionic blockade was 134±4.9/82±4.1 mm Hg and 90±6/49±2.4 mm Hg in patients and in control subjects, respectively. During ganglionic blockade, plasma vasopressin concentration increased 24-fold in control subjects and <2-fold in patients. In patients, cold pressor testing, hand-grip testing, and upright posture all increased blood pressure excessively. In contrast, muscle sympathetic nerve activity was not increased at rest or during cold pressor testing. The phenylephrine dose that increased systolic blood pressure 12.5 mm Hg was 8.0±2.0 &mgr;g in patients and 135±35 &mgr;g in control subjects before ganglionic blockade and 5.4±0.4 &mgr;g in patients and 13±4.8 &mgr;g in control subjects during ganglionic blockade. Conclusions—In patients with monogenic hypertension and neurovascular contact, basal blood pressure was increased even during sympathetic and parasympathetic nerve traffic interruption. However, sympathetic stimuli caused an excessive increase in blood pressure. This excessive response cannot be explained by increased sympathetic nerve traffic or increased vascular sensitivity. Instead, we suggest that baroreflex buffering and baroreflex-mediated vasopressin release are severely impaired.

[1]  J. Tank,et al.  Reference values of indices of spontaneous baroreceptor reflex sensitivity. , 2000, American journal of hypertension.

[2]  Masaru Sugimachi,et al.  New analytic framework for understanding sympathetic baroreflex control of arterial pressure. , 1999, American journal of physiology. Heart and circulatory physiology.

[3]  J. Jordan,et al.  Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure. , 1999, Journal of the American Society of Nephrology : JASN.

[4]  S. Coley,et al.  Decrease of blood pressure by ventrolateral medullary decompression in essential hypertension , 1998, The Lancet.

[5]  R. Schmieder,et al.  Evidence against elevated sympathetic vasoconstrictor activity in borderline hypertension. , 1998, Journal of the American Society of Nephrology : JASN.

[6]  J. Jordan,et al.  Contrasting actions of pressor agents in severe autonomic failure. , 1998, The American journal of medicine.

[7]  J. Jordan,et al.  Uncoupling of the baroreflex by N(N)-cholinergic blockade in dissecting the components of cardiovascular regulation. , 1998, Hypertension.

[8]  J. Jordan,et al.  N(N)-nicotinic blockade as an acute human model of autonomic failure. , 1998, Hypertension.

[9]  G Mancia,et al.  Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. , 1998, Hypertension.

[10]  R. Furlan,et al.  Malignant vagotonia due to selective baroreflex failure. , 1997, Hypertension.

[11]  T. Wienker,et al.  Neurovascular compression at the ventrolateral medulla in autosomal dominant hypertension and brachydactyly. , 1997, Stroke.

[12]  H. Itoh,et al.  Neurovascular compression of the rostral ventrolateral medulla related to essential hypertension. , 1997, Hypertension.

[13]  H. Itoh,et al.  Pulsatile compression of the rostral ventrolateral medulla in hypertension. , 1997, Hypertension.

[14]  T. Wienker,et al.  Autosomal dominant hypertension and brachydactyly in a Turkish kindred resembles essential hypertension. , 1996, Hypertension.

[15]  T. Wienker,et al.  Severe autosomal dominant hypertension and brachydactyly in a unique Turkish kindred maps to human chromosome 12 , 1996, Nature Genetics.

[16]  M. White,et al.  Aging and cardiovascular responsiveness to β‐agonist in humans: Role of changes in β‐receptor responses versus baroreflex activity , 1994 .

[17]  Addison A. Taylor,et al.  Autonomic Control of Cardiovascular Function: Clinical Evaluation in Health and Disease , 1994, Journal of clinical pharmacology.

[18]  M. White,et al.  Aging and cardiovascular responsiveness to beta-agonist in humans: role of changes in beta-receptor responses versus baroreflex activity. , 1994, Clinical pharmacology and therapeutics.

[19]  J. Netterville,et al.  The diagnosis and treatment of baroreflex failure. , 1993, The New England journal of medicine.

[20]  M. Esler.  Clinical application of noradrenaline spillover methodology: delineation of regional human sympathetic nervous responses. , 1993, Pharmacology & toxicology.

[21]  M R Gaab,et al.  Arterial hypertension and neurovascular compression at the ventrolateral medulla. A comparative microanatomical and pathological study. , 1992, Journal of neurosurgery.

[22]  I. Meredith,et al.  Plasma Norepinephrine Responses to Head‐Up Tilt Are Misleading in Autonomic Failure , 1992, Hypertension.

[23]  M. Yahr,et al.  Hypotension‐induced vasopressin release distinguishes between pure autonomic failure and multiple system atrophy with autonomic failure , 1992, Neurology.

[24]  D. Goldstein,et al.  Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. , 1988, The Journal of clinical investigation.

[25]  J Strackee,et al.  Hemodynamic fluctuations and baroreflex sensitivity in humans: a beat-to-beat model. , 1987, The American journal of physiology.

[26]  M. Dujovny,et al.  Neurogenic Hypertension: Etiology and Surgical Treatment, II. Observations in an Experimental Nonhuman Primate Model , 1985, Annals of surgery.

[27]  S. Wolfson,et al.  Neurogenic Hypertension: Etiology and Surgical Treatment I. Observations in 53 Patients , 1985, Annals of surgery.

[28]  Miller,et al.  Orthostatic hypertension. Pathogenetic studies. , 1985, Hypertension.

[29]  M. Goldberg,et al.  Increased vascular beta2-adrenoceptor responsiveness in autonomic dysfunction. , 1984, Journal of the American College of Cardiology.

[30]  G. Robertson,et al.  Vasopressin response to orthostatic hypotension. Etiologic and clinical implications. , 1983, The American journal of medicine.

[31]  K. Baughman,et al.  Clinical diagnostic manual for the house officer , 1981 .

[32]  R. Arbogast,et al.  Greatly Enhanced Pressor Response to Antidiuretic Hormone in Patients with Impaired Cardiovascular Reflexes Due to Idiopathic Orthostatic Hypotension , 1980, Journal of cardiovascular pharmacology.

[33]  Jannetta Pj,et al.  Clinical observations on etiology of essential hypertension. , 1979 .

[34]  G. Robertson,et al.  Osmotic and non-osmotic stimulation of vasopressin release [proceedings]. , 1979, The Journal of endocrinology.

[35]  P. Jannetta,et al.  Clinical observations on etiology of essential hypertension. , 1979, Surgical forum.

[36]  D. Eugene Hokanson,et al.  An Electrically Calibrated Plethysmograph for Direct Measurement of Limb Blood Flow , 1975, IEEE Transactions on Biomedical Engineering.

[37]  S. Karacadag,et al.  Hereditary Brachydactyly Associated with Hypertension , 1973, Journal of medical genetics.

[38]  R. Tarazi,et al.  Neurogenic participation in essential and renovascular hypertension assessed by acute ganglionic blockade: correlation with haemodynamic indices and intravascular volume. , 1973, Clinical science.

[39]  H. Goldblatt,et al.  Effects of various ganglionic blocking agents on blood pressure and on activity of pressor agents. , 1960, American Journal of Physiology.

[40]  D. Aviado.  Hemodynamic Effects of Ganglion Blocking Drugs , 1960 .

[41]  I. Page,et al.  Buffer reflexes, tolerance to ganglioplegics and their relationship to enhanced pressor responsiveness. , 1959, The American journal of physiology.